Roche Lietuva

What Roche Lietuva does

Roche Lietuva (UAB "Roche Lietuva") is the wholly-owned Lithuanian operating subsidiary of F. Hoffmann-La Roche Ltd, a Swiss multinational pharmaceutical and biotechnology company founded in 1896. Headquartered in Vilnius, the entity functions as the national sales, distribution, and service arm for three core business areas: Pharmaceuticals (specialty medicines in oncology, ophthalmology, haemophilia A, neurology including multiple sclerosis and NMOSD, immunology, and rare diseases), Diagnostics (instruments, reagents, and testing solutions), and Diabetes Care (the Accu-Chek blood glucose monitoring line). Supporting these divisions are a dedicated pharmacovigilance/drug safety hotline, a Technical Support Center, a diabetes product ordering service, and the RocheGydytojams.lt physician portal, which delivers medical information, product details, and clinical resources to Lithuanian healthcare professionals.

The underlying technology is developed and supplied by the parent group: proprietary biologics and small molecules for serious diseases, anti-VEGF inhibitors for intravitreal treatment of retinal conditions such as age-related macular degeneration and diabetic macular edema, extended half-life recombinant factors and non-factor therapies for haemophilia A, and diagnostic instruments paired with reagents. Roche Lietuva operates within an integrated diagnostics-plus-pharma model that supports personalized healthcare via molecular diagnostics-driven therapy selection, a capability anchored in the parent's R&D investment of over EUR 12 billion in 2020.

Commercially, the entity runs a direct enterprise field-sales motion targeting Lithuanian hospitals, clinics, physicians, and patients, with no publicly disclosed pricing. Revenue is generated through one-time sales of proprietary pharmaceuticals, hardware/reagent sales in diagnostics, and professional services for technical support. Customer engagement spans healthcare providers, patients (including treatment adherence, adverse-event reporting, and disease management), and regulatory bodies (transparency reporting to VĮ "Registrų centras"). The entity is also a member of the Innovative Pharmaceutical Industry Association (IFPA) and AmCham Lithuania, and uses IQVIA Ltd for IT support and data-management continuity.

Name

Roche Lietuva

Legal name

UAB "Roche Lietuva"

Website

https://roche.lt

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

Roche Lietuva is the Vilnius-based Lithuanian subsidiary of F. Hoffmann-La Roche Ltd, distributing specialty pharmaceuticals (oncology, ophthalmology, haemophilia, neurology, rare diseases), diagnostic instruments, and Accu-Chek diabetes care products to Lithuanian healthcare providers and patients via direct sales.

Ownership category

akta.pro rank

Product category

Pharmaceuticals and Diagnostics

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIACAC

Neurology & CNS Specialty Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

SECONDARYHLAIAAAF

Neurology & Psychiatry (CNS) Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAIAAAJ

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

• Pharmaceutical products
• Diagnostic instruments
• Diabetes care devices
• Oncology treatments
• Rare disease therapies

Headquarters

HQ city

Vilnius

HQ country

Lithuania

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Sales: Sale of proprietary medicines for serious diseases including oncology, neurology, haemophilia, and rare diseases to healthcare providers and patients in Lithuania
2. Diagnostic Products and Services: Sales of diagnostic devices, reagents, and technical support services for diagnostics and diabetes care (Accu-Chek products)
3. Technical Support Services: Technical assistance center providing support for diagnostics and diabetes care products, including a dedicated support line for sequencing solutions

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Roche Lietuva supplies innovative pharmaceutical medicines, in vitro diagnostic instruments and testing solutions, and diabetes care products (Accu-Chek) to Lithuanian healthcare providers and patients. Its pharmaceutical portfolio spans oncology, neurology (multiple sclerosis, NMOSD), ophthalmology (retinal vascular diseases), haemophilia A, and rare diseases, while the diagnostics division provides molecular and clinical laboratory testing platforms and the diabetes care line delivers blood glucose monitoring devices and consumables. The offering is complemented by a drug safety / pharmacovigilance service and a technical support center for instrument customers.

Product overview

Roche Lietuva operates as the Lithuanian subsidiary of F. Hoffmann-La Roche Ltd (Switzerland), offering a portfolio of pharmaceutical medications, diagnostic instruments, and diabetes care products. The company is organized into three core business areas: Farmacija (Pharmaceutical Solutions) developing innovative medicines for oncology, immunology, ophthalmology, neurology, haemophilia, and rare diseases; Diagnostika (Diagnostics) providing diagnostic instruments and testing solutions; and Diabetas (Diabetes Care) centered on the Accu-Chek brand for blood glucose monitoring. Supporting these core areas, Roche Lietuva provides drug safety/pharmacovigilance services, a physician portal (RocheGydytojams.lt), a technical support center for diagnostics, and a dedicated ordering service. The ophthalmology therapeutic focus covers age-related macular degeneration (AGDD), diabetic macular edema (DGDE), geographic atrophy, and retinal diseases, treated via anti-VEGF intravitreal injections. The neurology focus includes multiple sclerosis (MS/IS) and neuromyelitis optica spectrum disorder (NMOSD/ONSS). The company also publishes extensive patient education content through its website covering these therapeutic areas.

Differentiator

Problem solved

Functional benefit

Brands

• Accu-Chek: Diabetes care products including blood glucose meters and monitoring systems
• RocheGydytojams.lt

Products and services

• Pharmaceutical Solutions (Farmacijos sprendimai) Innovative prescription medicines covering oncology, neurology (multiple sclerosis, NMOSD), ophthalmology (retinal vascular disease), haemophilia A, and rare diseases, supplied to Lithuanian hospitals, specialty clinics, and prescribing physicians for the treatment of serious conditions.
• Diagnostics Solutions (Diagnostikos sprendimai) In vitro diagnostic instruments, reagents, and molecular diagnostic testing platforms for clinical laboratories and healthcare providers in Lithuania, supporting disease detection, monitoring, and companion-diagnostic-guided treatment decisions.
• Diabetes Care / Accu-Chek Accu-Chek blood glucose monitoring devices, test strips, lancing devices, and self-management solutions for people living with diabetes in Lithuania, supported by a free phone support line (8 800 11111) and the accu-chek.lt portal.
• Oncology Solutions (Onkologija) Targeted oncology therapies and associated molecular diagnostics for Lithuanian cancer patients, addressing multiple solid and haematological malignancies through hospital and specialist channels.
• Neurology Solutions (Neurologija) Innovative therapies for multiple sclerosis and neuromyelitis optica spectrum disorder (NMOSD), supplied to Lithuanian neurologists and specialist centres managing these chronic neurological conditions.
• Ophthalmology Solutions (Oftalmologijos sprendimai) Anti-VEGF and other targeted ophthalmic therapies for retinal vascular diseases, including diabetic macular oedema and age-related macular degeneration, supplied to Lithuanian eye-care specialists and hospitals.
• Haemophilia Solutions (Hemofilijos sprendimai) Haemophilia A treatment portfolio including extended half-life recombinant coagulation factors and non-factor replacement therapies, supplied to Lithuanian haematologists and haemophilia treatment centres along with patient information resources.
• Rare Disease Solutions (Retos ligos) Therapies for selected rare and ultra-rare diseases, supplied to Lithuanian specialist centres and physicians managing conditions with limited treatment alternatives.
• Drug Safety & Pharmacovigilance Service (Vaistų saugumo ir farmacijos priežiūros paslaugos) Adverse-event reporting and pharmacovigilance service for Roche medicines in Lithuania, with a dedicated 24/7 drug safety hotline (+370 5 254 67 99) and email channel used by patients, caregivers, and healthcare professionals.
• Technical Support Center for Diagnostics and Diabetes Care (Techninės Pagalbos Centras) Technical assistance and service for Roche diagnostic instruments and Accu-Chek / diabetes care devices used by Lithuanian laboratories, clinics, and patients, reachable by phone and email.
• Diagnostics and Diabetes Care Product Ordering Service Dedicated phone and email ordering channel for Roche diagnostics consumables and Accu-Chek diabetes care products in Lithuania, available during business hours.

Quantifiable outcome

• 23.4 billion diagnostic tools deployed in 2020
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Inovatyvios farmacijos pramonės asociacija (IFPA)minorOthersRoche Lietuva is a member of the Innovative Pharmaceutical Industry Association in Lithuania, adhering to industry ethics codes and transparency standards.
• Amerikos verslo rūmų (AmCham Lithuania)minorOthersRoche Lietuva is a member of the American Chamber of Commerce in Lithuania, supporting business standards and cross-border commerce.
• F. Hoffmann-La Roche LtdcoreOthersUAB Roche Lietuva operates as the Lithuanian subsidiary of F. Hoffmann-La Roche Ltd (Grenzacherstrasse 124, CH-4070 Basel, Switzerland), the global pharmaceutical and biotechnology company.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Merck Lietuva (MSD): Lithuanian operations of Merck & Co. (known as MSD outside North America), a global biopharmaceutical innovator in oncology, vaccines, and specialty care. Comparable as a peer multinational pharma subsidiary selling innovative branded therapies to Lithuanian healthcare providers.
• Bayer Lietuva: Lithuanian subsidiary of Bayer AG, offering pharmaceuticals (including ophthalmology via Eylea franchise) plus crop science and consumer health. Directly comparable in pharmaceutical scope, especially in retinal disease therapy where it competes with Roche's anti-VEGF franchise.
• AbbVie Lietuva: Lithuanian subsidiary of AbbVie Inc., a global biopharmaceutical company with a heavy specialty portfolio in immunology, oncology, and neuroscience. Comparable to Roche Lietuva in CNS and specialty care focus, operating with a similar specialty-pharma sales motion.
• AstraZeneca Lietuva: Lithuanian subsidiary of AstraZeneca PLC, a global biopharmaceutical company focused on oncology, rare diseases, and respiratory/inflammatory conditions. Directly comparable as a multinational pharma local affiliate with overlapping therapy areas and similar enterprise sales model.
• Johnson & Johnson Innovative Medicine Lietuva: Lithuanian subsidiary of Johnson & Johnson's Innovative Medicine division, selling branded specialty pharmaceuticals in oncology, immunology, and neuroscience. Comparable to Roche Lietuva in therapeutic focus and local-market enterprise distribution.
• Pfizer Lietuva: Lithuanian subsidiary of Pfizer Inc., a global biopharmaceutical company selling innovative branded drugs across multiple therapeutic areas. Directly comparable as another large multinational pharma subsidiary operating in Lithuania with similar enterprise field-sales motion.
• Novartis Lietuva: Lithuanian subsidiary of Novartis AG, another Swiss-headquartered global pharmaceutical major offering innovative branded medicines across oncology, neurology, ophthalmology, and cardiovascular — directly comparable to Roche Lietuva as a peer multinational pharma local affiliate in the same market.
• Sanofi Lietuva: Lithuanian affiliate of Sanofi S.A., a global pharmaceutical company with a strong specialty care portfolio (including rare diseases, neurology, immunology) plus vaccines and diabetes care. Comparable to Roche Lietuva across multiple shared therapy areas.
• Boehringer Ingelheim Lietuva: Lithuanian subsidiary of Boehringer Ingelheim, a global pharmaceutical company with franchises in respiratory, cardiometabolic, and specialty therapeutics. Directly comparable as another innovative pharma multinational operating in Lithuania with overlapping enterprise sales model.
• Amgen Lietuva: Lithuanian subsidiary of Amgen Inc., a global biotechnology company focused on oncology, cardiovascular, inflammation, and rare diseases using biologics. Comparable to Roche Lietuva as a peer multinational biotech subsidiary selling innovative specialty biologics in Lithuania.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/roche
• YouTubeyoutube.com/playlist?list=PLmXzuVn0p6GBXNSUjRfQ6GApZwxArXjt9
• Facebookfacebook.com/roche
• LinkedInlinkedin.com/company/roche-lietuva
• Instagraminstagram.com/roche

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roche Lietuva